Aspire Pharmaceuticals
2Patents
2Active
2Granted
38Portfolio score
Filing activity: Jul 22, 2013 → Jul 22, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD726899S1 | Chewable dosage form | General | 10 | Active |
| US10350296B1 | Chewable gelatin formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.